Supply Chain Ecosystem Analysis now part of DBMR Reports
Market Size in USD Billion
| 2022 –0 | |
|
|
|
| % | |
|
Global Apheresis Market, By Product (Apheresis Devices, Apheresis Disposables), Disease (Haematology, Autoimmune Diseases, Cardiovascular Diseases, Neurology, Metabolic Disorders, Renal Diseases), Procedure (Plasmapheresis, LDL-apheresis, Plateletpheresis, Photopheresis, Leukapheresis, Erythrocytapheresis, Therapeutic Cytapheresis), Technology (Centrifugation, Membrane Separation), End-User (Blood Collection Centres, Hospitals, Ambulatory Centres) – Industry Trends and Forecast to 2029
There has been in an increase in the use of apheresis in clinically ill patients lately, and is utilized as the primary therapy or as an adjunct to other therapies. The prevalence of chronic diseases is rising the demand for apheresis.
Apheresis refers to the medical technology that is usually deployed for the separation of different component of blood or purification of the blood. The technology consists of removing the blood from the patients of donor, and collecting it into an apparatus that separates the desired component from the blood. During the process the rest of the blood is sent back to the donor or patients.
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Forecast Period
|
2022 - 2029
|
|
Historic Years
|
2020 (Customizable to 2019 - 2014)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Product (Apheresis Devices, Apheresis Disposables), Disease (Haematology, Autoimmune Diseases, Cardiovascular Diseases, Neurology, Metabolic Disorders, Renal Diseases), Procedure (Plasmapheresis, LDL-apheresis, Plateletpheresis, Photopheresis, Leukapheresis, Erythrocytapheresis, Therapeutic Cytapheresis), Technology (Centrifugation, Membrane Separation), End-User (Blood Collection Centres, Hospitals, Ambulatory Centres)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
Fresenius Kabi AG (Germany), Kidde-Fenwal Inc. (US), Haemonetics Corporation (US), Isto Biologics (US), Asahi Kasei Medical Co. Ltd. (Japan), TERUMO BCT, INC (US), Otsuka Holdings Co., Ltd. (Japan), Bioelettronica Srl (Italy), HemaCare (US), TORAY INDUSTRIES, INC (Japan), Mallinckrodt (US), KANEKA CORPORATION (Japan), B. Braun Melsungen AG (Germany), Cerus Corporation (US), KAWASUMI LABORATORIES INC. (Japan), Nikkiso Co., Ltd. (Japan), Grifols, S.A. (Spain), and Medica S.p.A. (Italy) among others
|
This section deals with understanding the market drivers, advantages, opportunities, restraints and challenges. All of this is discussed in detail as below:
The rise in the prevalence of chronic diseases and increase in the number of trauma and injury cases across the globe acts as one of the major factors driving the growth of apheresis market.
The surge in demand for demand for source plasma from biopharmaceutical companies accelerate the market growth.
The increase in the demand for blood components and rise in concerns regarding blood safety will assist in the expansion of the apheresis market.
The presence of favourable reimbursement for apheresis procedures further influence the market.
The increase in demand for apheresis for leukemia and pediatric patients extend profitable opportunities to the market players in the forecast period of 2022 to 2029. Also, increase in the number of complex surgical procedures will further expand the market.
On the other hand, high cost of apheresis devices and therapeutic apheresis procedures and installation of apheresis devices is expected to obstruct market growth. Also, fewer blood donations using apheresis due to lack of awareness is projected to challenge the apheresis market in the forecast period of 2022-2029.
This apheresis market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on apheresis market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
The medical services such as apheresis witnessed decline in revenues in the years 2020 and 2021 due to the outbreak of COVID-19. Major medical procedures were declined during the pandemic in order to prevent the risk of spreading coronavirus. However, rise in the blood purification surgeries is expected in the post-COVID owing to the easing of restrictions.
The apheresis market is segmented on the basis of product, disease, procedure, technology and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
On the basis of product, the apheresis market is segmented into apheresis devices and apheresis disposables. Apheresis devices are further segmented into centrifugal apheresis devices and membrane separation devices.
Based on disease, the apheresis market is segmented into haematology, autoimmune diseases, cardiovascular diseases, neurology, metabolic disorders and renal diseases.
Based on procedure, the apheresis market is segmented into plasmapheresis, LDL-apheresis, plateletpheresis, photopheresis, leukapheresis, erythrocytapheresis, and therapeutic cytapheresis.
Based on technology, the apheresis market is segmented into centrifugation and membrane separation.
The apheresis market is also segmented on the basis of end-user into blood collection centres, hospitals and ambulatory centres.
The apheresis market is analysed and market size insights and trends are provided by country, product, disease, procedure, technology and end-user as referenced above.
The countries covered in the apheresis market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the apheresis market because of the large number of people suffering from different chronic diseases within the region.
Asia-Pacific (APAC) is expected to witness significant growth during the forecast period of 2022 to 2029 due to the increase in the demand for different blood components for the patients in the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
The apheresis market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for apheresis market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the apheresis market. The data is available for historic period 2010-2020.
The apheresis market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to apheresis market.
Some of the major players operating in the apheresis market are Fresenius Kabi AG (Germany), Kidde-Fenwal Inc. (US), Haemonetics Corporation (US), Isto Biologics (US), Asahi Kasei Medical Co. Ltd. (Japan), TERUMO BCT, INC (US), Otsuka Holdings Co., Ltd. (Japan), Bioelettronica Srl (Italy), HemaCare (US), TORAY INDUSTRIES, INC (Japan), Mallinckrodt (US), KANEKA CORPORATION (Japan), B. Braun Melsungen AG (Germany), Cerus Corporation (US), KAWASUMI LABORATORIES INC. (Japan), Nikkiso Co., Ltd. (Japan), Grifols, S.A. (Spain), and Medica S.p.A. (Italy) among others.
SKU-
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.